RhumbLine Advisers’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
ACM
OCMI
RhumbLine Advisers's ASPN Position: Q3 2026 in Review
RhumbLine Advisers increased its Aspen Aerogels (ASPN) stake by 0.43% in Q3 2026, buying an estimated $1.88K and bringing the position to 83,695 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #2783.
RhumbLine Advisers first reported a position in ASPN in Q2 2020 and has held it in 26 quarters since. The position peaked at $2.51M in Q3 2024. 135 funds tracked by Wall St. Rank hold ASPN as of Q3 2026.
- RhumbLine Advisers held 83,695 shares of Aspen Aerogels worth $459K as of Q3 2026.
- RhumbLine Advisers bought 360 Aspen Aerogels shares in Q3 2026, an estimated $1.88K.
- Aspen Aerogels made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #2783 holding.
- RhumbLine Advisers first reported a position in Aspen Aerogels in Q2 2020 and has held it in 26 quarters since.
- RhumbLine Advisers's Aspen Aerogels position peaked at $2.51M in Q3 2024.
- 135 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.